Keyence
80.270,00 ¥Variación respecto al cierre anterior: −1,15 %Variación absoluta: −930,00 ¥
En resumen
- Crecimiento de los ingresos
- +10,40 %
- Ej. a mar 2026 frente a Ej. a mar 2025
- Crecimiento del beneficio neto
- +11,67 %
- Ej. a mar 2026 frente a Ej. a mar 2025
- Margen neto
- 38,1 %
- Ej. a mar 2025: 37,6 %
Datos financieros
Importes en millones de JPY; valores por acción en JPY; acciones en millones.
| Partida | T2 2026 | T1 2026 | T4 2025 | T3 2025 | T2 2025 | T1 2025 | T4 2024 | T3 2024 | T2 2024 | T1 2024 | T4 2023 | T3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos totales | 346.621 | 334.684 | 311.995 | 284.224 | 261.076 | 283.955 | 271.798 | 268.327 | 247.223 | 260.099 | 241.109 | 243.806 |
| Coste de ventas | 51.866 | 55.361 | 52.065 | 49.010 | 45.412 | 46.864 | 44.573 | 42.467 | 39.831 | 42.401 | 40.099 | 41.679 |
| Beneficio bruto | 294.755 | 279.323 | 259.930 | 235.214 | 215.664 | 237.091 | 227.225 | 225.860 | 207.392 | 217.698 | 201.010 | 202.127 |
| Gastos generales, de venta y administración | 107.679 | 67.107 | 81.721 | 92.335 | 86.363 | 55.494 | 84.319 | 85.301 | 83.986 | 57.015 | 79.160 | 75.738 |
| Investigación y desarrollo | — | 32.839 | 16.420 | — | — | 28.856 | — | — | — | 25.183 | — | — |
| Resultado operativo | 187.076 | 179.377 | 161.790 | 142.879 | 129.301 | 152.741 | 142.906 | 140.559 | 123.406 | 135.500 | 121.850 | 126.389 |
| EBIT | 187.076 | 179.377 | 161.790 | 142.879 | 129.301 | 152.741 | 142.906 | 140.559 | 123.406 | 135.500 | 121.850 | 126.389 |
| EBITDA | 191.383 | 183.684 | — | 147.114 | — | 156.539 | 146.347 | 144.427 | 126.848 | 138.942 | 124.731 | 129.410 |
| Beneficio antes de impuestos | 196.793 | 192.142 | 175.378 | 153.468 | 131.531 | 150.673 | 147.646 | 134.274 | 131.443 | 141.735 | 123.651 | 133.088 |
| Impuestos | 57.660 | 58.124 | 52.765 | 45.625 | 39.415 | 43.782 | 43.178 | 38.088 | 37.909 | 38.519 | 36.266 | 39.179 |
| Beneficio neto | 139.133 | 134.018 | 122.613 | 107.843 | 92.116 | 106.891 | 104.468 | 96.186 | 93.534 | 103.216 | 87.385 | 93.909 |
| Beneficio neto para accionistas ordinarios | 139.133 | 134.018 | 122.613 | 107.843 | 92.116 | 106.891 | 104.468 | 96.186 | 93.534 | 103.216 | 87.385 | 93.909 |
| BPA básico | 573,68 | 552,59 | 505,57 | 444,67 | 379,82 | 440,74 | 430,75 | 396,60 | 385,67 | 425,59 | 360,31 | 387,21 |
| BPA diluido | 573,68 | 552,59 | 505,57 | 444,67 | 379,82 | 440,74 | 430,75 | 396,60 | 385,67 | 425,59 | 360,31 | 387,21 |
| Acciones medias (básicas) | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 |
| Acciones medias (diluidas) | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 | 243 |
| Dividendo por acción | — | 550,00 | — | 275,00 | — | 350,00 | 87,50 | 175,00 | — | 150,00 | — | 150,00 |
